TTM
$2.75B
YoY change
+66.9%
5Y CAGR
+4.7%
Peak year (2025)
$2.55B
Cumulative EBITDA
$13.29B
EBITDA history chart for Solventum (SOLV) from 2020 to 2025
Latest: $2.55B
EBITDA growth chart for Solventum (SOLV) from 2020 to 2025
Latest: +66.9%
EBITDA history table for Solventum (SOLV) from 2020 to 2025
| 2025 | $2.55B | +66.9% | +$1.02B | ||
| 2024 | $1.53B | -31.5% | −$701.00M | ||
| 2023 | $2.23B | -1.9% | −$42.00M | ||
| 2022 | $2.27B | -8.4% | −$209.00M | ||
| 2021 | $2.48B | +22.2% | +$450.00M | ||
| 2020 | $2.03B | — | — |
- 2025$2.55B+66.9%
- 2024$1.53B-31.5%
- 2023$2.23B-1.9%
- 2022$2.27B-8.4%
- 2021$2.48B+22.2%
- 2020$2.03B—
EBITDA values are taken from Solventum's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EBITDA at Solventum (SOLV)
According to Solventum's latest reported financial statements, the company's current EBITDA (TTM) is $2.75B. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
2025's annual EBITDA for Solventum (SOLV) came in at $2.55B – surged 66.9% year-over-year.
Solventum EBITDA has grown on net over the period, with a +4.7% compound annual growth rate over 2020–2025 (5 years).
2025 marks the peak EBITDA at $2.55B, with the historical low of $1.53B recorded in 2024.
Solventum EBITDA by Year
Solventum EBITDA 2025: $2.55B
2025's EBITDA for Solventum came in at $2.55B, surged 66.9% from 2024. This figure represents the highest annual value in the available history.
Solventum EBITDA 2024: $1.53B
Solventum posted EBITDA of $1.53B in 2024, plunged 31.5% below 2023. This figure represents the lowest annual value in the available history.
Solventum EBITDA 2023: $2.23B
In 2023, Solventum reported EBITDA of $2.23B, edged down 1.9% below 2022.
Solventum EBITDA 2022: $2.27B
Solventum EBITDA in 2022 was $2.27B, declined 8.4% below 2021.
Solventum EBITDA 2021: $2.48B
Solventum EBITDA in 2021 was $2.48B.
See more financial history for Solventum (SOLV).
Sector peers by EBITDA
Healthcare peers of Solventum (SOLV), ranked by their latest EBITDA
| $41.05B | |
| $28.26B | |
| $27.94B | |
| $24.43B | |
| $23.06B | |
| $19.83B | |
| $17.63B | |
| $16.90B |
- $41.05B
- $28.26B
- $27.94B
- $24.43B
- $23.06B
- $19.83B
- $17.63B
- $16.90B
Frequently asked questions
Solventum (SOLV) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation